SEC Comment Letter 0000000000-24-000397 to BIOREGENX, INC. (BRGX) (CIK 0001593184) (BRGX)
BIOREGENX, INC. (BRGX) (CIK 0001593184)
Date: Jan. 11, 2024 · CIK: 0001593184 · Accession: 0000000000-24-000397
AI Filing Summary & Sentiment
File numbers found in text: 000-56345
Show Raw Text
United States securities and exchange commission logo
January 11, 2024
Thomas Powers
Chief Executive Officer
Findit, Inc.
5051 Peachtree Corners Circle, #200
Peachtree Corners, GA 30092
Re:Findit, Inc.
Revised Information Statement on Schedule 14C
Filed January 3, 2024
File No. 000-56345
Dear Thomas Powers:
We have reviewed your filing and have the following comments.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments. Unless
we note otherwise, any references to prior comments are to comments in our February 17,
2023 letter.
Revised Information Statement on Schedule 14C
Information About Findit
Management's Discussion and Analysis of Financial Condition, page 56
1.Please update the management's discussion and analysis of financial condition to include
the fiscal year ended December 31, 2022. Refer to Item 14(c)(1) of Schedule 14A.
Information Incorporated by Reference, page 132
2.We note your response to prior comment 3. Please revise to remove this section as you
appear to be ineligible to incorporate by reference pursuant to Item 14(e)(1) to Schedule
14A.
FirstName LastNameThomas Powers
Comapany NameFindit, Inc.
January 11, 2024 Page 2
FirstName LastName
Thomas Powers
Findit, Inc.
January 11, 2024
Page 2
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Jeff Kauten at 202-551-3447 or Jan Woo at 202-551-3453 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Thomas C. Cook, Esq.